Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Chen

Showing results (191-200 of 280) with videos related to

Pageof 28
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 19, 2011
Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in childrenRyan M Swinney, Joke Beuten, Anderson B Collier, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1989
Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteersT L Chen, G B Vogelsang, B G Petty, et al.
Statistics in Medicine|January 29, 2005
Evaluating current policy for detecting mosaicism in amniotic fluid cultures: implications for current cell counting practicesSamuel P Caudill, Daniel L Van Dyke, Andrew T L Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I and pharmacologic study of sequences of paclitaxel and cyclophosphamide supported by granulocyte colony-stimulating factor in women with previously treated metastatic breast cancerM J Kennedy, M L Zahurak, R C Donehower, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1991
In vivo induction of bone by recombinant human transforming growth factor beta 1L S Beck, A J Ammann, T B Aufdemorte, et al.
Oncogene|May 11, 2004
CCND1 polymorphism and age of onset of hepatoblastomaSamart Pakakasama, Tina T-L Chen, William Frawley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumorsS O'Reilly, L B Grochow, R C Donehower, et al.
Cancer Research|February 15, 1995
Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantationT L Chen, J L Passos-Coelho, D A Noe, et al.
Cancer Treatment Reports|January 1, 1987
High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trialS M Longnecker, R C Donehower, A E Cates, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer: a phase 2 studyH A Hahm, D K Armstrong, T L Chen, et al.
Pageof 28

Showing results (191-200 of 280) with videos related to

Sort By:
Pageof 28
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 19, 2011
Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in childrenRyan M Swinney, Joke Beuten, Anderson B Collier, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1989
Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteersT L Chen, G B Vogelsang, B G Petty, et al.
Statistics in Medicine|January 29, 2005
Evaluating current policy for detecting mosaicism in amniotic fluid cultures: implications for current cell counting practicesSamuel P Caudill, Daniel L Van Dyke, Andrew T L Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I and pharmacologic study of sequences of paclitaxel and cyclophosphamide supported by granulocyte colony-stimulating factor in women with previously treated metastatic breast cancerM J Kennedy, M L Zahurak, R C Donehower, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1991
In vivo induction of bone by recombinant human transforming growth factor beta 1L S Beck, A J Ammann, T B Aufdemorte, et al.
Oncogene|May 11, 2004
CCND1 polymorphism and age of onset of hepatoblastomaSamart Pakakasama, Tina T-L Chen, William Frawley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumorsS O'Reilly, L B Grochow, R C Donehower, et al.
Cancer Research|February 15, 1995
Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantationT L Chen, J L Passos-Coelho, D A Noe, et al.
Cancer Treatment Reports|January 1, 1987
High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trialS M Longnecker, R C Donehower, A E Cates, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer: a phase 2 studyH A Hahm, D K Armstrong, T L Chen, et al.
Pageof 28